Notes
accessed through the Canadian Agency for Drugs and Technologies in Health (CADTH)
Reference
Maraiki F, et al. International HTA Experience with Targeted Therapy Approvals for Lung Cancer PharmacoEconomics-Open : 3 Aug 2018. Available from: URL: https://doi.org/10.1007/s41669-018-0088-x
Rights and permissions
About this article
Cite this article
Low listing success rate for novel lung cancer therapies. PharmacoEcon Outcomes News 810, 22 (2018). https://doi.org/10.1007/s40274-018-5213-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5213-7